No association of genetic variants in BDNF with major depression: A meta- and gene-based analysis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 1, 2013, Pages 61-70

  Gyekis, Joseph P ^a   Yu, Weihong ^b   Dong, Shuqian ^c   Wang, Haina ^d   Qian, Jun ^b   Kota, Pravina ^e   Yang, Jingyun ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

BDNF; Gene based analysis; Major depressive disorder; Meta analysis; Polymorphism

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ARTICLE; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFORMATION RETRIEVAL; MAJOR DEPRESSION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ADULT; AMINO ACID SUBSTITUTION; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84871309406     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32122     Document Type: Article

References (65)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association Press.
2. Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, Lehtimaki T. 2007. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm 114: 1065-1068.
3. Chen L, Lawlor DA, Lewis SJ, Yuan W, Abdollahi MR, Timpson NJ, Day IN, Ebrahim S, Smith GD, Shugart YY. 2008. Genetic association study of BDNF in depression: Finding from two cohort studies and a meta-analysis. Am J Med Genet Part B 147B: 814-821.
4. Chen L, Wang Y, Xiao H, Wang L, Wang C, Guo S, Zhao Y, Hua P, Liu W, Zhang N. 2011. The 712A/G polymorphism of brain-derived neurotrophic factor is associated with Parkinson's disease but not major depressive disorder in a Chinese Han population. Biochem Biophys Res Commun 408: 318-321.
5. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, et al. 2006. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140-143.
6. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS. 2004. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24: 4401-4411.
7. Chi MH, Chang HH, Lee SY, Lee IH, Gean PW, Yang YK, Lu RB, Chen PS. 2010. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder. J Affect Disord 126: 430-435.
8. Chi MH, Lee SY, Chang HH, Yang YK, Lin E, Chen PS. 2011. Comparison of antidepressant efficacy-related SNPs among Taiwanese and four populations in the HapMap database. J Formos Med Assoc 110: 478-482.
9. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS. 2006. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 1118: 176-182.
10. Cole J, Weinberger DR, Mattay VS, Cheng X, Toga AW, Thompson PM, Powell-Smith G, Cohen-Woods S, Simmons A, McGuffin P, et al. 2011. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes Brain Behav 10: 756-764.
11. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
12. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
13. Enoch MA, White KV, Waheed J, Goldman D. 2008. Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders. Depress Anxiety 25: 383-392.
14. Fisher RA. 1932. Statistical methods for research workers. Edinburgh: Oliver and Boyd. xiii p, 1 l. p.
15. Frodl T, Schule C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, et al. 2007. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 64: 410-416.
16. Glasziou PP, Sanders SL. 2002. Investigating causes of heterogeneity in systematic reviews. Stat Med 21: 1503-1511.
17. Gratacos M, Soria V, Urretavizcaya M, Gonzalez JR, Crespo JM, Bayes M, de Cid R, Menchon JM, Vallejo J, Estivill X. 2008. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics J 8: 101-112.
18. Groves JO. 2007. Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12: 1079-1088.
19. Hartung J. 1999. A note on combining dependent tests of significance. Biometrical J 41: 849-855.
20. Hofer MM, Barde YA. 1988. Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature 331: 261-262.
21. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. 2003. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48: 186-189.
22. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. 2006. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 27: 1834-1837.
23. Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, et al. 2007. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet Part B 144B: 1003-1006.
24. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, Harris CR, Marini AM, Enoch MA, Lipsky RH. 2005. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30: 1353-1361.
25. Jones KR, Reichardt LF. 1990. Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc Natl Acad Sci USA 87: 8060-8064.
26. Kanellopoulos D, Gunning FM, Morimoto SS, Hoptman MJ, Murphy CF, Kelly RE, Glatt C, Lim KO, Alexopoulos GS. 2011. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am J Geriatr Psychiatry 19: 13-22.
27. Kato M, Serretti A. 2010. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 15: 473-500.
28. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. 2003. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105.
29. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS. 2008. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging 29: 789-792.
30. Kim SJ, Cho SJ, Jang HM, Shin J, Park PW, Lee YJ, Cho IH, Choi JE, Lee HJ. 2010. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 61: 19-26.
31. Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, Weale ME, Schosser A, Paredes UM, Rivera M, et al. 2010. Genome-wide association study of major recurrent depression in the U.K population. Am J Psychiatry 167: 949-957.
32. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, van Duijn CM. 2008. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 13: 772-785.
33. Maisonpierre PC, Le Beau MM, Espinosa R III, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME, Yancopoulos GD. 1991. Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations. Genomics 10: 558-568.
34. McClearn GE. 2006. Contextual genetics. Trends Genet 22: 314-319.
35. Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, et al. 2010. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 15: 589-601.
36. Neale BM, Sham PC. 2004. The future of association studies: Gene-based analysis and replication. Am J Hum Genet 75: 353-362.
37. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
38. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C, Mendlewicz J. 2005. No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: Evidence from Belgian first and replication patient-control studies. Eur Neuropsychopharmacol 15: 491-495.
39. Ozan E, Okur H, Eker C, Eker OD, Gonul AS, Akarsu N. 2010. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 81: 61-65.
40. Pae CU, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Serretti A, De Ronchi D. 2012. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder, and schizophrenia. Neuropsychobiology 65: 1-11.
41. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. 2004. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24: 10099-10102.
42. Phillips TJ, Hen R, Crabbe JC. 1999. Complications associated with genetic background effects in research using knockout mice. Psychopharmacology (Berl) 147: 5-7.
43. Plomin R, Haworth CM, Davis OS. 2010. Genetics of learning abilities and disabilities: Recent developments from the UK and possible directions for research in China 2008. Behav Genet 40: 297-305.
44. Quinn CR, Dobson-Stone C, Outhred T, Harris A, Kemp AH. 2012. The contribution of BDNF and 5-HTT polymorphisms and early life stress to the heterogeneity of major depressive disorder: A preliminary study. Aust N Z J Psychiatry 46: 55-63.
45. Ribeiro L, Busnello JV, Cantor RM, Whelan F, Whittaker P, Deloukas P, Wong ML, Licinio J. 2007. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport 18: 1291-1293.
46. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmal C, Hofels S, et al. 2005. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58: 307-314.
47. Sheng X, Yang J. 2012. Truncated product methods for panel unit root tests. Oxf Bull Econ Stat DOI: 10.1111/j.1468-0084.2012.00705.x
48. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR Jr, Gejman PV, Sanders AR, et al. 2011. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 16: 193-201.
49. Simes RJ. 1986. An improved bonferroni procedure for multiple tests of significance. Biometrika 73: 751-754.
50. Smith MA, Makino S, Kvetnansky R, Post RM. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15: 1768-1777.
51. Spencer JL, Waters EM, Milner TA, Lee FS, McEwen BS. 2010. BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function. Proc Natl Acad Sci USA 107: 4395-4400.
52. Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, et al. 2009. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol Psychiatry 14: 359-375.
53. Sullivan PF, Neale MC, Kendler KS. 2000. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 157: 1552-1562.
54. Sun RF, Zhu YS, Kuang WJ, Liu Y, Li SB. 2011. The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neurosci Lett 489: 34-37.
55. Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, Luben R, Day NE, Flint J. 2007. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 41: 404-409.
56. Taylor WD, Zuchner S, McQuoid DR, Steffens DC, Blazer DG, Krishnan KR. 2008. Social support in older individuals: The role of the BDNF Val66Met polymorphism. Am J Med Genet Part B 147B: 1205-1212.
57. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ. 2003. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet Part B 123B: 19-22.
58. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. 2004. Global burden of depressive disorders in the year 2000. Br J Psychiatry 184: 386-392.
59. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B. 2010. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: Effects of gender and ethnicity. Mol Psychiatry 15: 260-271.
60. Videbech P, Ravnkilde B. 2004. Hippocampal volume and depression: A meta-analysis of MRI studies. Am J Psychiatry 161: 1957-1966.
61. Wang H, Dong S, Xu H, Qian J, Yang J. 2012a. Genetic variants in FTO associated with metabolic syndrome: A meta- and gene-based analysis. Mol Biol Rep 39: 5691-5698.
62. Wang L, Ashley-Koch A, Steffens DC, Krishnan KR, Taylor WD. 2012b. Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. Genes Brain Behav 11: 352-359.
63. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS. 2002. Truncated product method for combining P-values. Genet Epidemiol 22: 170-185.
64. Zhang K, Yang C, Xu Y, Sun N, Yang H, Liu J, Xu Q, Shen Y. 2010. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm 117: 393-401.
65. Zou YF, Ye DQ, Feng XL, Su H, Pan FM, Liao FF. 2010. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur Neuropsychopharmacol 20: 535-544.